KANDAN KULANDAIVEL
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology ABINGTON, PA NPI 1104089119
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology PA ABBVIE INC. All categories
General Payments — all program years on this page
$15,948.02
- Category: General Payments
- Program years: PY2018–2024
- Record count: 403
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,026.43 across 46 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,026.43 | 46 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $266.61 | 15 |
| ARGENX US, INC. | $165.61 | 6 |
| Celgene Corporation | $164.12 | 3 |
| SK Life Science, Inc. | $69.54 | 4 |
| Lundbeck LLC | $62.51 | 3 |
| Merz Pharmaceuticals, LLC | $39.37 | 2 |
| Alexion Pharmaceuticals, Inc. | $39.09 | 2 |
| CSL Behring | $26.65 | 1 |
| Acerta Pharma LLC | $25.41 | 1 |
| MDD US Operations, LLC | $22.56 | 1 |
| Ipsen Biopharmaceuticals, Inc | $21.39 | 1 |
| GENZYME CORPORATION | $20.33 | 1 |
| Teva Pharmaceuticals USA, Inc. | $20.27 | 1 |
| Genentech USA, Inc. | $18.58 | 1 |
| Axsome Therapeutics, Inc. | $17.38 | 1 |
| Grifols USA, LLC | $17.33 | 1 |
| Sumitomo Pharma America, Inc. | $15.83 | 1 |
| Azurity Pharmaceuticals, Inc. | $13.85 | 1 |
By program year
Records — PY2024 (46)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.